
Life sciences job openings · Updated 2026-07-28
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
From official company newsrooms and press releases.
Company description, mission, culture, and benefits — visible after this page is claimed and verified.
Sign up free to search all 5 openings with AI-powered matching.
Search Immunovant JobsProfile generated from publicly available hiring data.
·Are you Immunovant? Claim this page or contact us